Ionoven

Magnesium Chloride Hexahydrate, the active ingredient in Ionoven, is an electrolyte solution presented as an intravenous solution for IV use. It provides magnesium, potassium, sodium, and acetate ions to replace lost electrolytes and support fluid balance in patients requiring intravenous therapy, such as those with dehydration, surgery, or critical illness.

GNH USA supplies Ionoven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product meets EU quality standards and is distributed under strict regulatory compliance.

Ionoven is used in clinical situations that require rapid restoration of electrolyte balance and intravascular volume.

- Electrolyte replacement: restores magnesium, potassium, sodium and acetate levels in patients with documented deficits. - Fluid resuscitation: contributes to intravascular volume expansion during acute dehydration or shock. - Correction of electrolyte imbalances: normalises serum concentrations in surgical, intensive‑care or renal‑impairment settings.

Ionoven may be associated with a range of infusion‑related reactions.

Common Side Effects: - Mild hypermagnesemia: transient elevation of serum magnesium. - Hyperkalemia: modest increase in serum potassium. - Infusion site irritation: redness or discomfort at the catheter site. - Mild hypotension: temporary drop in blood pressure. - Nausea or vomiting. - Headache.

Serious or Rare Side Effects: - Severe hypermagnesemia: risk of cardiac conduction abnormalities. - Life‑threatening arrhythmias due to electrolyte excess. - Anaphylactic or severe allergic reaction. - Marked hypotension or shock. - Metabolic acidosis from acetate overload. - Severe electrolyte disturbances requiring immediate medical intervention.

When using Ionoven, clinicians should observe several safety measures. - Assess baseline electrolyte levels: verify serum magnesium, potassium and sodium before infusion. - Monitor cardiac rhythm: watch for arrhythmias during and after administration. - Adjust dosing in renal impairment: reduced clearance may require slower infusion or lower concentration. - Use caution in patients with heart block or severe cardiac disease. - Avoid rapid infusion: administer at recommended rate to prevent circulatory overload. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Ionoven can interact with other medications that affect electrolyte balance.

Major Interactions (Avoid): - Concurrent IV potassium chloride solutions: risk of severe hyperkalemia. - Calcium gluconate or calcium chloride: may precipitate with magnesium. - Magnesium sulfate infusions: additive hypermagnesemia. - Loop diuretics administered simultaneously: can cause abrupt shifts in electrolytes.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor renal function and potassium levels. - NSAIDs: may impair renal excretion of electrolytes. - Digoxin: potassium fluctuations can alter drug toxicity. - Antacids containing magnesium or aluminum: assess total magnesium load. - Thiazide diuretics: may potentiate electrolyte disturbances.